Grief After Overdose and Substance Use: Evidence in GA

Learn what a survey of overdose-bereaved adults found about changes in substance use and grief symptoms, and why its results cannot predict one person's course.

Empty chairs arranged around a low table in a softly lit room.

Losing someone to an opioid overdose can raise difficult questions about grief, substance use, and mental health. Research can describe patterns among people who participated in a study, but it cannot predict how one bereaved adult will respond. A U.S. survey found associations between recalled increases in substance use after an overdose loss and greater current mental health symptom severity. Those findings deserve attention without being turned into a claim that grief inevitably leads to addiction. Understanding who participated, what researchers measured, and what they could not establish is essential to interpreting the results.

How do grief reactions and timelines vary?

Grief does not follow one required emotional sequence or timetable. Individual circumstances matter, a distinction also reflected in River City Recovery's explanation of how personal needs shape an individualized addiction treatment plan. For questions about its general outpatient scope, the River City Recovery contact page describes available program discussions. Neither resource establishes a grief diagnosis or changes what the bereavement evidence can show about a particular person.

The VA National Center for PTSD's grief guidance explains that responses can involve physical, emotional, mental, and social changes. Its page, updated September 25, 2026, is general grief education rather than an overdose-bereavement study. The guidance describes variation rather than a checklist everyone must experience:

  • Physical responses may include disrupted sleep and restlessness.
  • Emotional experiences can include sadness, loneliness, anger, anxiety, or guilt.
  • Concentration, decision-making, identity, and expectations about the future may change.
  • Social experiences can include withdrawal, loneliness, or difficulty developing relationships.

The VA also explains that grief can come in waves. Intense feelings may return even as someone gradually regains balance. The familiar idea of moving through five fixed stages does not accurately describe everyone's course. Differences in the relationship, circumstances of death, coping patterns, and living environment can all matter.

Prolonged or complicated grief refers in the VA source to a prolonged, impairing reaction, not simply to remembering someone for many years. The distinction involves significant distress or interference with functioning. The overdose survey similarly describes prolonged grief disorder in terms of extended grief accompanied by debilitating symptoms. Neither description makes an isolated feeling, a difficult anniversary, or the passage of time sufficient for self-diagnosis.

Common grief experiences and impairing reactions can share features, such as sadness or difficulty accepting a death. Context and functioning therefore matter. A list of possible experiences cannot establish whether a person has a disorder, and general grief guidance does not establish that any particular reaction causes increased substance use.

Who participated in the overdose-bereavement survey?

The study included U.S. adults grieving an opioid overdose death, supporting someone living with opioid use disorder, or doing both. This research population is different from people seeking care through River City Recovery admissions, and participation did not establish a need for a particular program. The distinction between research-group characteristics and personal needs is consistent with the broader context of individualized addiction care planning.

The 2025 study, “A hidden crisis: Associations between overdose bereavement, substance use, and mental health,” used an anonymous online survey. The report was available in PMC in January 2026 and accessed November 6, 2026. Its methods do not identify a survey collection date range. Eligible participants were at least 18, lived in the United States, had sufficient English proficiency, and had the relevant supporting or bereavement experience.

Recruitment occurred through three peer-support organizations that shared survey information with members and social media followers. Participants were also encouraged to share the survey through their own networks. These convenience and snowball methods helped researchers reach people with relevant experiences, but they did not produce a representative sample of all overdose-bereaved adults.

The final sample contained 158 participants: 45 who were grieving, 44 who were supporting someone, and 69 who were both grieving and supporting. Calling all 158 participants overdose-bereaved would therefore be inaccurate. The sample was 84% female and 87% white, with a median age of 58. These characteristics limit how confidently findings can be extended to younger adults, men, and people from other racial or ethnic backgrounds.

Researchers also reviewed survey records for fraud, attention problems, missing information, and other validity concerns before selecting the final sample. Those checks address data quality, but they cannot eliminate recruitment bias. People connected to support organizations may differ from people who never seek such support, whether in symptom burden, coping resources, or other circumstances.

There was no comparison group consisting of adults who were neither supporting someone with opioid use disorder nor grieving an overdose death. The survey therefore cannot fully separate the effects of these experiences from differences that might exist in a broader population.

What did the substance-use questions actually measure?

Participants recalled whether their substance use changed during the year after a specific event; researchers did not track their consumption prospectively. That distinction separates a research measure from the current circumstances considered in an individualized treatment plan. Likewise, the assessment discussions described on the River City Recovery contact page concern present care questions, not assigning someone the average characteristics of a survey group.

In the U.S. online survey's substance-use methods, participants described changes in weekly amounts of alcohol, opioids, cannabis, stimulants, and sedatives. Bereaved respondents answered about the year following the overdose death. Supporting-only respondents answered about the year after learning of their close other's opioid use. Those are related but different reference events.

For participants who had experienced multiple overdose losses, researchers asked them to focus on the most impactful loss. The results therefore do not describe each death separately or establish how cumulative losses affected every respondent.

MeasureWhat participants reportedImportant boundary
Substance-specific changeRecalled change in weekly use during the following yearNot a prospective record of exact consumption
Any substance-use increaseAn increase in at least one of five substance categoriesNot equivalent to a new substance use disorder diagnosis
Current mental health symptomsSymptom severity when completing the surveyNot a pre-loss measurement or a record of symptom onset
Prolonged grief symptomsA grief measure completed by bereaved participantsResearch scoring does not diagnose an individual reader

Response options ranged from a large increase to stopping entirely or never using the substance. For analysis, researchers combined small and large increases into one category. Other responses became “did not increase.” Consequently, that comparison category included several different patterns, not just unchanged use.

The summary measure also did not distinguish an increase in one substance from increases in several. It answered whether any increase was recalled, not precisely how much someone used, why they used it, or whether they developed a disorder. Those distinctions prevent a broad research category from being mistaken for a detailed personal substance-use history.

What associations appeared, and why are they not causal?

In this selected U.S. online sample, recalled increases in substance use were associated with greater current symptoms of prolonged grief, PTSD, depression, and substance use disorder. These associations do not determine the content of an individualized addiction treatment plan or establish eligibility for services described through River City Recovery's admissions contact. Research associations and individual care decisions answer different questions.

The survey's regression results associated losing a child to opioid overdose with a greater likelihood of reporting increased substance use during the following year, including alcohol and sedative use. Losing a contemporary, such as a sibling, cousin, or friend, was associated with increased sedative use. These are findings within the recruited sample, not predictions about all bereaved parents or friends.

Across the relevant models, reporting any substance-use increase was associated with higher current PTSD, depression, and substance use disorder symptom severity. Among 103 participants bereaved for at least 180 days, it was also associated with greater prolonged grief symptom severity. Losing a child was separately associated with higher prolonged grief severity in that analysis. The 180-day restriction describes the researchers' method at the time, not a self-diagnosis rule.

The findings were not uniform across all substances and outcomes. The anxiety regression model was not significant. No significant predictors of increased cannabis or stimulant use were found, and only seven participants reported increased opioid use. Those low opioid counts prevented interpretation of that regression model. A nonsignificant result does not establish that no relationship exists, especially in a small sample.

Researchers also conducted exploratory path modeling involving participants whose reference events occurred more than a year before survey completion. Those models identified indirect statistical relationships involving bereavement, recalled increased use, and current symptoms. However, a model that fits survey responses cannot supply missing observations from the past.

The authors acknowledged alternative explanations. More severe early grief, limited social support, or broader difficulties adjusting might relate to both increased use and later symptoms. Existing substance-use problems might also matter, but the survey did not establish participants' pre-event substance use disorder histories.

These results concern self-reported experiences and symptom measures, not an electronic health record analysis of newly coded diagnoses. They should not be presented as evidence of a documented sequence from bereavement to a newly diagnosed disorder. Nor did the observational study test whether any intervention prevented increased use or improved grief outcomes.

What can adults in GA reasonably infer?

The findings support taking a person's grief and substance-use history seriously without assuming either follows a universal course. River City Recovery's guide to individualized addiction treatment plans explains why personal circumstances matter within general care planning. Adults seeking information about its published outpatient options can contact River City Recovery in Columbus, GA. Neither the guide nor the contact information establishes specialty overdose-bereavement services.

The survey offers evidence about associations in a selected U.S. sample, not a Georgia prevalence estimate. Its recruitment, demographic composition, and focus on opioid-related experiences matter. An overdose death, another sudden death, an anticipated death, and other forms of loss cannot automatically be treated as interchangeable research populations.

Relationship categories also require care. The study grouped several relationships together because many individual categories contained few participants. That practical analytical choice does not mean siblings, cousins, and friends have identical experiences. The survey did not measure relationship strength, so a category label cannot fully describe the significance of a particular loss.

Several questions help keep the evidence in proportion:

  • Who was studied? U.S. adults reached largely through peer-support networks, including bereaved and supporting-only participants.
  • What was recalled? Changes in substance use during a past year, sometimes several years before the survey.
  • What was measured currently? Mental health symptom severity when respondents completed the online assessment.
  • What remains unknown? Baseline symptoms, detailed prior substance-use histories, causal direction, and how well findings generalize beyond this sample.

The VA's guidance on varied grief reactions provides a complementary boundary: people can differ substantially in how they grieve. Variation should not be mistaken for proof that a particular person is unaffected, and distress should not automatically be labeled a disorder.

The most defensible conclusion is specific. In this cross-sectional survey, recalled substance-use increases after relevant opioid-related events were associated with greater current symptom severity. That observation identifies a relationship worth understanding. It does not establish inevitability, diagnose a reader, prove that grief causes a substance use disorder, or demonstrate the effectiveness of a particular treatment.

Frequently asked questions

Does everyone bereaved by overdose increase substance use?

No. The survey did not find that everyone increased substance use, and its selected sample cannot establish a universal response. Participants could report increases, decreases, no change, stopping, or never using a substance. Researchers grouped these responses for analysis, so an association between bereavement circumstances and increased use does not predict one person's behavior.

What does prolonged grief mean in the source context?

The VA describes prolonged or complicated grief as a prolonged, impairing reaction involving significant distress or interference with functioning. The study discusses extended grief accompanied by debilitating symptoms and uses a research symptom measure. Neither source suggests that continuing to remember someone, experiencing occasional intense feelings, or reaching a particular date alone establishes a diagnosis.

Does the study prove grief causes a substance use disorder?

No. This was a cross-sectional survey combining recalled substance-use changes with current symptom measurements. Researchers lacked pre-loss mental health measurements and detailed prior substance use disorder histories. Earlier distress, existing substance-related problems, or other circumstances could help explain the associations. Statistical path modeling did not overcome those missing observations or establish causation.

Can overdose-bereavement study results be applied to every kind of loss?

Not automatically. This U.S. survey focused on opioid overdose bereavement and supporting someone with opioid use disorder, with recruitment largely through peer-support networks. Different loss circumstances, relationships, populations, and sampling methods may produce different findings. Its results are not a prevalence estimate for Georgia or a prediction for every bereaved adult.

Explore related information from River City Recovery

Contact River City Recovery